Proton magnetic resonance spectroscopy in multiple sclerosis

Area of Science:

• Neuroimaging
• Biochemistry
• Neurology

Background:

• Multiple Sclerosis (MS) is a chronic neurological disease characterized by inflammation and neurodegeneration.
• Understanding the metabolic alterations in MS is crucial for diagnosis and treatment monitoring.
• Proton magnetic resonance spectroscopy (¹H-MRS) offers non-invasive in vivo metabolic insights.

Purpose of the Study:

• To review the role of ¹H-MRS in assessing metabolic changes in MS lesions and normal-appearing brain and spinal cord tissue.
• To explore the utility of ¹H-MRS in evaluating therapeutic efficacy in MS patients.
• To highlight ¹H-MRS as a tool for understanding MS pathogenesis and disease progression.

Main Methods:

• Review of existing literature on ¹H-MRS applications in multiple sclerosis.
• Analysis of metabolic data from MS lesions, normal-appearing white matter, gray matter, and spinal cord.
• Evaluation of studies assessing therapeutic interventions using ¹H-MRS.

Main Results:

• ¹H-MRS detects specific metabolic alterations in MS lesions and affected tissues.
• Metabolic profiles can differentiate between lesion types and disease stages.
• ¹H-MRS provides objective markers for monitoring treatment response.

Conclusions:

• ¹H-MRS is a valuable tool for characterizing MS pathophysiology and disease evolution.
• Metabolic information from ¹H-MRS aids in assessing disease severity and prognosis.
• ¹H-MRS enables objective evaluation of therapeutic interventions in MS.